Cargando…

Cutaneous Involvement in Diseases with Plasma Cell Differentiation: Diagnostic Approach

Neoplasms with plasma cell differentiation may occasionally involve the skin. Cutaneous lesions may represent the first sign of an underlying systemic plasma cell malignancy, such as multiple myeloma, or the skin itself may be the primary site of occurrence of a hematological tumor with plasma cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Zanelli, Magda, Palicelli, Andrea, Sanguedolce, Francesca, Zizzo, Maurizio, Filosa, Alessandra, Ricci, Linda, Cresta, Camilla, Martino, Giovanni, Bisagni, Alessandra, Zanetti, Eleonora, di Donato, Francesco, Melli, Beatrice, Soriano, Alessandra, Cimino, Luca, Cavazza, Alberto, Vivian, Lisa Francesca, Ascani, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139249/
https://www.ncbi.nlm.nih.gov/pubmed/35621636
http://dx.doi.org/10.3390/curroncol29050246
_version_ 1784714815339495424
author Zanelli, Magda
Palicelli, Andrea
Sanguedolce, Francesca
Zizzo, Maurizio
Filosa, Alessandra
Ricci, Linda
Cresta, Camilla
Martino, Giovanni
Bisagni, Alessandra
Zanetti, Eleonora
di Donato, Francesco
Melli, Beatrice
Soriano, Alessandra
Cimino, Luca
Cavazza, Alberto
Vivian, Lisa Francesca
Ascani, Stefano
author_facet Zanelli, Magda
Palicelli, Andrea
Sanguedolce, Francesca
Zizzo, Maurizio
Filosa, Alessandra
Ricci, Linda
Cresta, Camilla
Martino, Giovanni
Bisagni, Alessandra
Zanetti, Eleonora
di Donato, Francesco
Melli, Beatrice
Soriano, Alessandra
Cimino, Luca
Cavazza, Alberto
Vivian, Lisa Francesca
Ascani, Stefano
author_sort Zanelli, Magda
collection PubMed
description Neoplasms with plasma cell differentiation may occasionally involve the skin. Cutaneous lesions may represent the first sign of an underlying systemic plasma cell malignancy, such as multiple myeloma, or the skin itself may be the primary site of occurrence of a hematological tumor with plasma cell differentiation. Starting from examples encountered in our daily practice, we discussed the diagnostic approach pathologists and clinicians should use when faced with cutaneous lesions with plasma cell differentiation. Cases of primary cutaneous marginal zone lymphoma, localized primary amyloidosis/amyloidoma, and cutaneous manifestations (secondary either to multiple myeloma or to plasmablastic lymphoma) are discussed, focusing on the importance of the adequate patient’s work-up and precise clinicopathological correlation to get to the correct diagnosis and appropriate treatment. The pertinent literature has been reviewed, and the clinical presentation, pathological findings, main differential diagnoses, treatment, and outcome of neoplasms with plasma cell differentiation involving the skin are discussed.
format Online
Article
Text
id pubmed-9139249
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91392492022-05-28 Cutaneous Involvement in Diseases with Plasma Cell Differentiation: Diagnostic Approach Zanelli, Magda Palicelli, Andrea Sanguedolce, Francesca Zizzo, Maurizio Filosa, Alessandra Ricci, Linda Cresta, Camilla Martino, Giovanni Bisagni, Alessandra Zanetti, Eleonora di Donato, Francesco Melli, Beatrice Soriano, Alessandra Cimino, Luca Cavazza, Alberto Vivian, Lisa Francesca Ascani, Stefano Curr Oncol Article Neoplasms with plasma cell differentiation may occasionally involve the skin. Cutaneous lesions may represent the first sign of an underlying systemic plasma cell malignancy, such as multiple myeloma, or the skin itself may be the primary site of occurrence of a hematological tumor with plasma cell differentiation. Starting from examples encountered in our daily practice, we discussed the diagnostic approach pathologists and clinicians should use when faced with cutaneous lesions with plasma cell differentiation. Cases of primary cutaneous marginal zone lymphoma, localized primary amyloidosis/amyloidoma, and cutaneous manifestations (secondary either to multiple myeloma or to plasmablastic lymphoma) are discussed, focusing on the importance of the adequate patient’s work-up and precise clinicopathological correlation to get to the correct diagnosis and appropriate treatment. The pertinent literature has been reviewed, and the clinical presentation, pathological findings, main differential diagnoses, treatment, and outcome of neoplasms with plasma cell differentiation involving the skin are discussed. MDPI 2022-04-24 /pmc/articles/PMC9139249/ /pubmed/35621636 http://dx.doi.org/10.3390/curroncol29050246 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Zanelli, Magda
Palicelli, Andrea
Sanguedolce, Francesca
Zizzo, Maurizio
Filosa, Alessandra
Ricci, Linda
Cresta, Camilla
Martino, Giovanni
Bisagni, Alessandra
Zanetti, Eleonora
di Donato, Francesco
Melli, Beatrice
Soriano, Alessandra
Cimino, Luca
Cavazza, Alberto
Vivian, Lisa Francesca
Ascani, Stefano
Cutaneous Involvement in Diseases with Plasma Cell Differentiation: Diagnostic Approach
title Cutaneous Involvement in Diseases with Plasma Cell Differentiation: Diagnostic Approach
title_full Cutaneous Involvement in Diseases with Plasma Cell Differentiation: Diagnostic Approach
title_fullStr Cutaneous Involvement in Diseases with Plasma Cell Differentiation: Diagnostic Approach
title_full_unstemmed Cutaneous Involvement in Diseases with Plasma Cell Differentiation: Diagnostic Approach
title_short Cutaneous Involvement in Diseases with Plasma Cell Differentiation: Diagnostic Approach
title_sort cutaneous involvement in diseases with plasma cell differentiation: diagnostic approach
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139249/
https://www.ncbi.nlm.nih.gov/pubmed/35621636
http://dx.doi.org/10.3390/curroncol29050246
work_keys_str_mv AT zanellimagda cutaneousinvolvementindiseaseswithplasmacelldifferentiationdiagnosticapproach
AT palicelliandrea cutaneousinvolvementindiseaseswithplasmacelldifferentiationdiagnosticapproach
AT sanguedolcefrancesca cutaneousinvolvementindiseaseswithplasmacelldifferentiationdiagnosticapproach
AT zizzomaurizio cutaneousinvolvementindiseaseswithplasmacelldifferentiationdiagnosticapproach
AT filosaalessandra cutaneousinvolvementindiseaseswithplasmacelldifferentiationdiagnosticapproach
AT riccilinda cutaneousinvolvementindiseaseswithplasmacelldifferentiationdiagnosticapproach
AT crestacamilla cutaneousinvolvementindiseaseswithplasmacelldifferentiationdiagnosticapproach
AT martinogiovanni cutaneousinvolvementindiseaseswithplasmacelldifferentiationdiagnosticapproach
AT bisagnialessandra cutaneousinvolvementindiseaseswithplasmacelldifferentiationdiagnosticapproach
AT zanettieleonora cutaneousinvolvementindiseaseswithplasmacelldifferentiationdiagnosticapproach
AT didonatofrancesco cutaneousinvolvementindiseaseswithplasmacelldifferentiationdiagnosticapproach
AT mellibeatrice cutaneousinvolvementindiseaseswithplasmacelldifferentiationdiagnosticapproach
AT sorianoalessandra cutaneousinvolvementindiseaseswithplasmacelldifferentiationdiagnosticapproach
AT ciminoluca cutaneousinvolvementindiseaseswithplasmacelldifferentiationdiagnosticapproach
AT cavazzaalberto cutaneousinvolvementindiseaseswithplasmacelldifferentiationdiagnosticapproach
AT vivianlisafrancesca cutaneousinvolvementindiseaseswithplasmacelldifferentiationdiagnosticapproach
AT ascanistefano cutaneousinvolvementindiseaseswithplasmacelldifferentiationdiagnosticapproach